Renaud, C.O.;                     Ziros, P.G.;                     Mathias, A.;                     Pot, C.;                     Sykiotis, G.P.    
        Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study. Antioxidants 2022, 11, 1015.
    https://doi.org/10.3390/antiox11051015
    AMA Style
    
                                Renaud CO,                                 Ziros PG,                                 Mathias A,                                 Pot C,                                 Sykiotis GP.        
                Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study. Antioxidants. 2022; 11(5):1015.
        https://doi.org/10.3390/antiox11051015
    
    Chicago/Turabian Style
    
                                Renaud, Cédric O.,                                 Panos G. Ziros,                                 Amandine Mathias,                                 Caroline Pot,                                 and Gerasimos P. Sykiotis.        
                2022. "Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study" Antioxidants 11, no. 5: 1015.
        https://doi.org/10.3390/antiox11051015
    
    APA Style
    
                                Renaud, C. O.,                                 Ziros, P. G.,                                 Mathias, A.,                                 Pot, C.,                                 & Sykiotis, G. P.        
        
        (2022). Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study. Antioxidants, 11(5), 1015.
        https://doi.org/10.3390/antiox11051015